Prognostic significance of treatment‐induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|23|3676-3682

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.23, 2014-12, pp. : 3676-3682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 2, 2015-02 ,pp. : 152-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1 adaptive dose‐finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high‐risk extremity and trunk soft tissue sarcoma

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3659-3667

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic options and postoperative wound complications after extremity soft tissue sarcoma resection and postoperative external beam radiotherapy

By  

INTERNATIONAL WOUND JOURNAL, Vol. 15, Iss. 1, 2018-02 ,pp. : 148-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma

By  

CANCER, Vol. 122, Iss. 17, 2016-09 ,pp. : 2624-2632

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma

By  

Cardiology in the Young, Vol. 27, Iss. 9, 2017-08 ,pp. : 1815-1822

Cambridge University Press

Access to resources Recommend Favorite